A holistic evaluation of sexual health disease investigation: case study of the 2022 Mpox outbreak in Santa Clara County, California
Harit Agroia
A * , Leyla Mousli A and Disha Nangia A
A
Abstract
Despite its integral role in preventing and controlling infectious diseases, there is limited research that evaluates the impact of disease investigation (DI) services. The County of Santa Clara Public Health Department activated its emergency response operations, which included designated DI services, to respond to its local Mpox outbreak. The aim of this evaluation was to understand the range of outcomes achieved through Mpox DI services.
Mpox investigations completed between June and December 2022 were included in an evaluation that employed a composite measure to calculate the number of investigations needed to achieve the following outcomes: (1) treatment completion, (2) monitoring completion, (3) partial vaccine dose completion, (4) full vaccination series completion, and (5) STI and HIV testing.
The overall composite score of 0.53 indicated that each investigation led to 1.90 outcomes achieved. Among cases eligible for treatment, 2.16 investigations yielded one treatment completion; 1.19 case and contact investigations yielded one monitoring completion; 2.21 and 3.53 contact investigations yielded one partial vaccine dose completion and one full vaccination series completion, respectively; and 2.25 case and contact investigations yielded one STI or HIV test.
Recognizing the multiple steps involved in DI can inform holistic evaluations that illuminate intervention impact.
Keywords: composite measure, disease investigation, infectious disease, Mpox, outbreak response, program evaluation, public health, sexual health.
References
1 Centers for Disease Control and Prevention. About Mpox. 2024. Available at https://www.cdc.gov/mpox/about/?CDC_AAref_Val=https://www.cdc.gov/poxvirus/mpox/about/index.html
2 Centers for Disease Control and Prevention. Past U.S. Cases and Outbreaks. 2023. Available at https://www.cdc.gov/mpox/outbreaks/past-us-cases/index.html
3 Centers for Disease Control and Prevention. Clinical overview of Mpox. 2024. Available at https://www.cdc.gov/mpox/hcp/clinical-overview/index.html#:~:text=or%20confirmed%20mpox-,All%20sexually%20active%20adults%20and%20adolescents%20in%20whom%20mpox%20is,for%20severe%20manifestations%20of%20mpox
4 Shwartz M, Restuccia JD, Rosen AK. Composite measures of health care provider performance: a description of approaches. Milbank Q 2015; 93(4): 788-25.
| Crossref | Google Scholar | PubMed |
5 Peterson ED, DeLong ER, Masoudi FA, O’Brien SM, Peterson PN, Rumsfeld JS, et al. ACCF/AHA 2010 position statement on composite measures for healthcare performance assessment. Circulation 2010; 121(15): 1780-91.
| Crossref | Google Scholar | PubMed |
6 Kara P, Valentin JB, Mainz J, Johnsen SP. Composite measures of quality of health care: evidence mapping of methodology and reporting. PLoS ONE 2022; 17(5): e0268320.
| Crossref | Google Scholar | PubMed |
7 Agroia H, Smith E, Vaidya A, Rudman S, Roy M. Monkeypox (Mpox) vaccine hesitancy among Mpox cases: a qualitative study. Health Promot Pract 2023; 15248399231215054.
| Crossref | Google Scholar |
8 Laprise C, Bolster-Foucault C. Understanding barriers and facilitators to HIV testing in Canada from 2009–2019: a systematic mixed studies review. Can Commun Dis Rep 2021; 47(2): 105-25.
| Crossref | Google Scholar |
9 Groves AK, Stankard P, Bowler SL, Jamil MS, Gebrekristos LT, Smith PD, et al. A systematic review and meta-analysis of the evidence for community-based HIV testing on men’s engagement in the HIV care cascade. Int J STD AIDS 2022; 33(13): 1090-105.
| Crossref | Google Scholar | PubMed |
10 Oza S, Chen F, Selser V, Clougherty MM, Dale KD, Johnson JI, et al. Community-based outbreak investigation and response: enhancing preparedness, public health capacity, and equity. Health Aff 2023; 42(3): 349-56.
| Crossref | Google Scholar | PubMed |
